Kaiser Gypsum Co.

Company History & West Coast Operations

Kaiser Gypsum Company emerged from the broader Kaiser industrial empire, one of the most consequential American industrial conglomerates of the twentieth century. Henry J. Kaiser built his fortune on large-scale infrastructure projects during the 1930s and 1940s—his consortium helped construct Hoover Dam, Grand Coulee Dam, and Bonneville Dam—before pivoting aggressively into manufacturing during World War II. Kaiser shipyards on the West Coast produced more cargo vessels than any other American builder, and after the war the Kaiser organization diversified into steel, aluminum, cement, and construction materials to serve the postwar building boom that was already reshaping California and the Pacific Northwest.

Kaiser Aluminum & Chemical Corporation became the parent entity for a range of building products businesses, and Kaiser Gypsum Company operated as one of these subsidiaries. The company was strategically positioned to serve the California construction market, which was experiencing explosive growth driven by returning veterans, the baby boom, suburban expansion, and the state’s relentless population surge. California added millions of residents between 1945 and 1975, and the demand for gypsum wallboard and finishing compounds was enormous. Kaiser Gypsum supplied this demand from manufacturing facilities concentrated in the San Francisco Bay Area and nearby communities in the East Bay, with distribution networks extending north to Oregon and Washington and south through the entire California coast.

The company’s relationship to Hanson Permanente Cement, another Kaiser-related entity operating out of the Bay Area, reflected the interlocking nature of the Kaiser industrial family. Permanente had been Kaiser’s wartime cement operation, and the network of Kaiser building materials companies—gypsum, cement, aluminum—gave the organization an integrated position in the postwar construction supply chain. Kaiser Gypsum leveraged this network to become one of the dominant suppliers of interior finishing products throughout the western states during the peak construction decades of the 1950s and 1960s.

Like virtually every manufacturer of joint compound during this era, Kaiser Gypsum incorporated chrysotile asbestos into its formulations. Asbestos improved the workability of joint compound, strengthening the dried film, reducing cracking, and making the product easier to feather at edges. These were genuine performance advantages in the days before synthetic fiber additives became available, and they were understood at the time as technological improvements rather than health hazards. Industry standards and building codes embraced asbestos-containing joint compound without restriction throughout most of the 1950s and 1960s, and Kaiser Gypsum sold these products in enormous quantities to California’s booming construction sector.

As evidence of asbestos health risks accumulated through the late 1960s and early 1970s, regulatory pressure built on manufacturers. The Environmental Protection Agency and the Occupational Safety and Health Administration both moved to restrict asbestos use, and Kaiser Gypsum, like its competitors, transitioned to asbestos-free formulations during the mid-1970s. However, the products already installed and sanded across California, Oregon, and Washington during the preceding two decades remained in place in millions of homes, apartment buildings, offices, and schools—and the workers who had applied them were already carrying asbestos fibers in their lungs.

The company continued operations as part of various Kaiser corporate restructurings over the following decades. Kaiser Industries had begun divesting major holdings in the 1970s and 1980s. The gypsum operations passed through successive ownership arrangements even as asbestos litigation began mounting against the company’s historical products in the 1990s and accelerating into the 2000s. The sheer volume of claims from West Coast construction workers diagnosed with mesothelioma, asbestosis, and asbestos-related lung cancer ultimately drove the company to seek bankruptcy protection in September 2016—not because the underlying business was insolvent, but because the asbestos liability had become unmanageable outside of the structured relief that only federal bankruptcy reorganization could provide.

Products & Asbestos Exposure

Kaiser Gypsum manufactured a range of interior construction products, but its joint compounds are the most significant from an asbestos exposure standpoint. Joint compound—also called taping mud or drywall mud—is applied over gypsum board seams and fastener dimples, then sanded smooth once dry to create the seamless wall surfaces that define modern interior construction. It was this sanding step that created the most dangerous exposures, because dry sanding of asbestos-containing compound released fine chrysotile fibers into the air at concentrations far above any safe level. Studies conducted on drywall finishing workers in the early 1970s found that sanding asbestos-containing joint compounds generated fiber counts many times above then-current permissible exposure limits, even in spaces that appeared reasonably ventilated.

The joint compound products are of particular concern because chrysotile fibers released during sanding are extremely fine—so small that they are invisible to the naked eye and remain suspended in still indoor air for hours. Workers who performed the final sanding step over careers measured in years or decades accumulated significant cumulative asbestos doses. Unlike insulation workers who might have episodic intense exposures, drywall finishers experienced repeated moderate-to-high exposures on nearly every working day, a pattern that epidemiological research has shown to carry substantial mesothelioma risk.

Secondary or bystander exposure was also common on busy job sites. Electricians, plumbers, HVAC installers, and other trades working in the same building while drywall finishers were sanding could inhale fibers without ever touching the Kaiser Gypsum product themselves. This bystander exposure pathway is well-documented in asbestos litigation and is recognized by the Kaiser Gypsum Trust in its exposure criteria. Homeowners who sanded their own drywall joints faced similar risks, often in smaller, even more poorly ventilated spaces than professional job sites.

Manufacturing Facilities

Kaiser Gypsum’s production infrastructure was concentrated on the West Coast, reflecting its target market and the Kaiser organization’s deep Bay Area roots. The company’s primary operations were in Northern California, where proximity to both raw gypsum deposits and the massive Bay Area construction market made the region ideal for manufacturing. Workers at these facilities faced occupational asbestos exposures distinct from those encountered by end-users of the finished products—the industrial environment of a manufacturing plant handling raw asbestos fiber as an ingredient created its own exposure profile, often more intense and sustained than what any individual construction worker would experience.

Workers employed at Kaiser Gypsum manufacturing and distribution facilities faced occupational asbestos exposure throughout the production process. At the Antioch plant and related Northern California operations, employees who handled raw asbestos fiber during formulation, operated mixing equipment, or packaged finished joint compound could inhale asbestos-laden dust at concentrations far higher than those encountered on individual construction job sites. These exposures occurred over full working careers for many plant employees, creating cumulative doses that substantially elevated their lifetime mesothelioma risk.

Maintenance workers at these facilities also faced episodic but potentially intense exposures when repairing or replacing industrial pipe insulation, boiler lagging, and other equipment components that themselves contained asbestos from other manufacturers. This is an important complication in asbestos trust fund claims: most workers who were heavily exposed at Kaiser Gypsum facilities were also exposed to asbestos-containing products from other companies, and experienced asbestos attorneys identify all responsible manufacturers when building a compensation strategy.

Western States Workers Most Affected

The California construction boom of the postwar decades was unlike anything the state had seen before. Between 1950 and 1970, California’s population grew from roughly 10.5 million to over 20 million people—nearly doubling in a single generation. Every new resident needed housing. Every housing unit required drywall. Every drywalled surface required joint compound. Kaiser Gypsum, positioned at the heart of the Bay Area with distribution reaching every corner of the state, was ideally placed to supply this demand, and it did so at enormous scale throughout the 1950s and 1960s.

The workers who suffered the consequences were the skilled tradespeople who built California’s postwar suburbs and cities: the drywall tapers working tract home subdivisions in the San Fernando Valley, the Inland Empire, and the East Bay; the finish carpenters and painters preparing apartment buildings for tenants in San Francisco, San Jose, and Sacramento; the commercial drywall crews hanging and finishing office buildings, schools, hospitals, and government facilities throughout the state. These workers used Kaiser Gypsum joint compound as a matter of course—it was available, affordable, and performed well—without any awareness that the chrysotile fibers they were inhaling during each sanding operation were accumulating in the pleural lining of their lungs.

Specific occupational groups with particularly high exposure risk from Kaiser Gypsum products include:

• Drywall tapers and finishers: The tradespeople most directly exposed, spending much of each workday sanding dried joint compound in enclosed interior spaces. This occupation carried the highest per-worker exposure levels from Kaiser Gypsum products.
• Plasterers and stucco workers: Workers who applied texture coatings and plaster finishes, many of whom also used Kaiser Gypsum texture products containing chrysotile fibers.
• Painters: Painters performing surface preparation on previously drywalled walls frequently sanded joint compound to smooth imperfections before priming, creating the same fiber-release hazard as the original finishing operation.
• Carpenters and drywall hangers: Workers who installed drywall panels and cut them to fit around doors, windows, and fixtures generated airborne dust from both the gypsum core and any asbestos-containing facing materials.
• General construction laborers: Laborers who cleaned up job sites, moved materials, and worked in close proximity to drywall finishing operations sustained bystander exposures that could be substantial over a career of construction work.
• Remodeling and renovation contractors: Even workers who entered the trade after Kaiser Gypsum had ceased asbestos-containing production faced exposure when they disturbed pre-1975 drywall during renovation projects on existing buildings.

Oregon and Washington experienced parallel dynamics on a smaller scale. The Portland metropolitan area grew rapidly through the 1950s and 1960s driven by timber industry prosperity and industrial expansion, and Seattle’s economy expanded on the strength of Boeing and the defense industry. Construction workers in both cities and their surrounding communities used Kaiser Gypsum products supplied through the company’s Pacific Northwest distribution network. Nevada and Arizona, especially the Las Vegas and Phoenix metropolitan areas, were also significant markets as Sun Belt growth accelerated through the 1960s.

The long latency period for asbestos-related diseases—typically 20 to 50 years from first exposure to clinical diagnosis—explains the timing of the asbestos litigation wave against Kaiser Gypsum. A construction worker who spent the 1960s sanding Kaiser Gypsum joint compound throughout California’s building boom would not have been diagnosed with mesothelioma until the 1980s at the earliest, more likely the 1990s or 2000s, and sometimes not until well into the 2010s or beyond. This biological latency is precisely why Kaiser Gypsum faced an accelerating wave of asbestos lawsuits decades after its products left the market, and why the Kaiser Gypsum Asbestos Personal Injury Trust continues to receive new claims today from workers and their families dealing with diagnoses that trace back to construction work performed fifty or more years ago.

Renovation workers represent a continuing second wave of exposure. When older California homes and commercial buildings are remodeled today—when drywall is cut, removed, or sanded in structures finished with Kaiser Gypsum joint compound during the asbestos era—dormant chrysotile fibers in those walls become airborne again. The risk is lower than it was during original construction, because the fibers are partially bound within the dried compound matrix, but it is not negligible. Contractors doing gut-renovation work in pre-1975 California construction without proper respiratory protection and asbestos abatement protocols continue to face meaningful exposure risk.

Kaiser Gypsum Asbestos Trust Fund

Kaiser Gypsum Company filed for Chapter 11 bankruptcy protection in the United States Bankruptcy Court in September 2016. The filing was made in the Western District of North Carolina, a jurisdiction that had developed significant institutional expertise handling asbestos-related corporate reorganizations over the preceding two decades. The company’s stated purpose in seeking bankruptcy protection was to permanently resolve its asbestos liabilities through a structured trust mechanism rather than continuing to litigate thousands of individual cases in state and federal courts across California and other western states.

Bankruptcy proceedings in asbestos cases are governed by Section 524(g) of the United States Bankruptcy Code, which provides a specific framework for resolving mass asbestos tort liability through a bankruptcy reorganization. The debtor company proposes a reorganization plan that includes the creation of an asbestos personal injury trust, funded with assets contributed by the debtor and, where applicable, parent or affiliated entities. Once the trust is established and the reorganization plan is confirmed by the court, all present and future asbestos personal injury claims against the reorganized company are channeled exclusively to the trust. The company itself receives a permanent injunction against further asbestos litigation. This “channeling injunction” is the primary incentive for companies to fund these trusts adequately, and the requirement that claimants’ representatives vote in favor of the plan ensures that trust funding levels are negotiated at arm’s length.

The Kaiser Gypsum reorganization plan was confirmed by the bankruptcy court after an extensive proceeding involving Kaiser Gypsum’s parent entities, asbestos claimants’ representatives, and insurance carriers. The Kaiser Gypsum Asbestos Personal Injury Trust was formally established in 2021, several years after the original bankruptcy filing, reflecting the complexity of negotiating and confirming a large asbestos reorganization. The Trust is administered by independent trustees and operates under a Trust Distribution Procedures document that governs every aspect of the claims process: eligibility requirements, disease category definitions, payment values, evidentiary standards, and administrative procedures.

The disease categories recognized by the Kaiser Gypsum Trust are consistent with those established by other major asbestos trusts. They include:

• Mesothelioma (all types, including pleural, peritoneal, and pericardial): The most directly asbestos-attributable disease, receiving the highest scheduled payment values and expedited review. Claimants diagnosed with mesothelioma are not required to address alternative causation issues.
• Lung Cancer: Recognized as an asbestos-related malignancy when accompanied by sufficient evidence of occupational asbestos exposure and, in most Trust frameworks, either a diagnosed non-malignant asbestos disease or specific occupational exposure criteria. Smoking history is considered in many Trust frameworks.
• Laryngeal Cancer and Esophageal Cancer: Recognized in many asbestos trust distributions as asbestos-related malignancies with documented associations with heavy cumulative asbestos exposure.
• Asbestosis: Diffuse pulmonary fibrosis caused by asbestos fiber deposition in the lung tissue, typically requiring medical imaging and pulmonary function testing to document.
• Other Non-Malignant Conditions: Including pleural plaques, diffuse pleural thickening, and pleural effusion associated with asbestos exposure, typically requiring documentation of both the medical condition and functional impairment.

Mesothelioma claimants receive the most favorable treatment in terms of both payment levels and processing speed. The expedited review pathway for mesothelioma allows for faster payment without the same level of documentary scrutiny as claims for conditions where asbestos causation must be established against competing explanations. Given that mesothelioma is extraordinarily rare in the absence of asbestos exposure, the Trust’s approach to these claims reflects sound medical and legal reasoning.

To file a claim, a claimant or their legal representative submits a completed Proof of Claim form and Claim Summary Form to the Trust’s claims processing facility. Supporting documentation must include medical records confirming the diagnosis (pathology reports, imaging studies, physician statements) and exposure documentation establishing that the claimant was meaningfully exposed to Kaiser Gypsum asbestos-containing products. Exposure documentation may include sworn declarations from the claimant or former coworkers, employment records, work history affidavits, contractor records from job sites, and similar evidence. The Trust reviews submitted claims against its eligibility criteria and issues payment offers based on the scheduled values in the Trust Distribution Procedures.

California construction workers and their survivors should understand that filing with the Kaiser Gypsum Trust is almost always one part of a broader legal strategy rather than the totality of available compensation. Most workers who were exposed to Kaiser Gypsum products were also exposed to asbestos from numerous other manufacturers over their careers—pipe and boiler insulation, floor tiles, ceiling tiles, gaskets, spray-on fireproofing, and other products from entirely separate companies that also established asbestos trusts. Experienced asbestos attorneys routinely identify all potentially responsible manufacturers and file claims against each relevant trust simultaneously, which can substantially increase total recovery without any additional burden on the claimant. The Kaiser Gypsum Trust claim is a component of a complete case, not the entire case.

All initial consultations with asbestos attorneys are provided free of charge, and virtually all asbestos attorneys work on a contingency fee basis, meaning their compensation comes as a percentage of any recovery rather than hourly fees paid by the client. This arrangement means that diagnosed workers and their families face no financial barrier to obtaining professional legal guidance about trust fund claims, regardless of their current financial situation.

Frequently Asked Questions